NASDAQ:ASND
Ascendis Pharma A/S Stock News
$134.00
-3.20 (-2.33%)
At Close: May 06, 2024
ArrowMark Colorado Holdings LLC Invests $1.67 Million in Ascendis Pharma A/S (NASDAQ:ASND)
09:10am, Friday, 20'th Mar 2020
ArrowMark Colorado Holdings LLC purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 12,000 shares of the biotechnol
Ascendis Pharma (ASND) Received its Third Buy in a Row
08:14pm, Thursday, 19'th Mar 2020
After Cantor Fitzgerald and Morgan Stanley gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another Buy, this time from
Ascendis Pharma (ASND) Received its Third Buy in a Row
08:14pm, Thursday, 19'th Mar 2020
After Cantor Fitzgerald and Morgan Stanley gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another
Ascendis Pharma initiated with an Outperform at Oppenheimer ASND
09:08am, Thursday, 19'th Mar 2020
Ascendis Pharma initiated with an Outperform at Oppenheimer Oppenheimer ASND
